Search

John Hodgson, St. Joseph’s Hospital and Medical Center, Phoenix American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta The TYPHOON study from Paris – as report

Peter Smith, Duke University Medical Center, Durham, NC Late Breaking Clinical Trials, ACC Atlanta 2006, Sunday 12th March 2006 The drug pexelizumab, targeting inflammation, reduced the risk of death

Bruce Neal, The George Institute, University of Sydney Late Breaking Clinical Trials, ACC Atlanta 2006, Sunday 12th March 2006 Because high levels of salt consumption in rural areas of northern China

Deepak Bhatt, Cleveland Clinic, Ohio American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta The idea of adding clopidogrel anti-platelet therapy to standard aspirin therap

Gregg Stone, Columbia University Medical Center, New York American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta A superiority for the anti-clotting drug bivalirudin for t

Michael Lincoff, Cleveland Clilnic, Cleveland Ohio American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta The full picture of how bivalirudin is emerging as a treatment wi

Reporting from: American Society of Hematology Meeting, Atlanta, 10-13 December 2005 In this edition: It is not necessary to use rituximab along with standard CVP (cyclophosphamide, vincristine, predi

Maria Kyrgiou, Hammersmith Hospital, London Abstract: Lancet 2006; 367: 489-98 A meta-analysis published in the Lancet has found that excising pre-cancerous lesions of the cervix can lead to problems

Chris Polman, Free University of Amsterdam Abstract N Engl J Med 2006;345:899 Despite fears that natalizumab – which reduces progression in some categories of patients with multiple sclerosis &#

Frans Van de Werf, University of Leuven Abstract Lancet 367:569-578 Results from a new study just published in the Lancet look into the role of facilitated PCI in patients with ST-elevation acute myoc

Ian D Pavord, Glenfield Hospital, University of Leicester Abstract N Engl J Med 2006 ; 354:697 A key underlying factor in severe asthma may have been uncovered according to findings now published in t

Matthew J Thompson, University of Oxford Abstract Lancet 2006; 367:397-403 More lives of children with meningococcal disease could be saved if previously overlooked early signs could be recognised by